Kent is a Senior Vice President of Strategy and leads Merkle’s Global Health Strategy practice. He has been consulting in the areas of pharmaceutical, provider, and payer strategy for more than 20 years. In addition to broad blog/whitepaper and conference activity, he is published extensively in a variety of journals including, Research in Social and Administrative Pharmacy, Formulary, the Journal of Clinical Pharmacy and Therapeutics, and the Journal of Database Marketing.
Kent has worked with a number of clients in the pharmaceutical, healthcare, and animal health vertical including AbbVie, AstraZeneca, BMS, Boehringer Ingelheim, Novartis, Sanofi (Genzyme, Chattem and Merial), OHSU, Emblem Health, and Anthem, focusing on engagement, communication, and CRM strategy in the US, Canada, Europe, and Australasia. He has a Ph.D. in pharmaceutical strategy and policy from Dalhousie University in Halifax, NS, and holds the position of Assistant Professor, Clinical Pharmacy, at the James L. Winkle College of Pharmacy, University of Cincinnati.
Kent's Articles, Blog Posts, Webinars and More
Healthcare Leadership During an Economic Downturn
The COVID-19 challenge is fluid; how long this “new normal” will last is anyone’s guess. What we expect is that all healthcare stakeholders to a greater or lesser extent will change behaviors permanently.
Topics:
Health & Wellness
Healthcare Leadership During an Economic Downturn: Actions to Take Now
Strong leadership, combined with the universal recognition (and conviction) that there is a new way forward, will be the key driver to success or failure among all organizations. Here are actions to take now.
Topics:
Health
|
Customer Strategy
Considerations as the US Contemplates a COVID-19-Driven Special Enrollment Period for Affordable Care
As the US contemplates a special enrollment period for affordable care, here is what insurers and the uninsured need to know in light of Covid-19.
The Health Marketer’s Imperatives
With healthcare being one of the most regulated industries, what are the biggest challenges and opportunities for marketers?
Topics:
Health
|
Customer Strategy
Three Steps to Deliver Personalized Healthcare Marketing in a Cookieless World
With the changes in privacy across the industry, what do health marketers need to know to deliver personalized experiences across channels?
Topics:
Data and Analytics
|
Health
Expanding Guardrails for the Customer-Centric Health Revolution
The California Consumer Privacy Act (CCPA) looms as the first general consumer privacy law that will affect all domestic US industries, including healthcare.
Topics:
Health
|
Data and Analytics
Patient Consent Required – It’s Not Your Data!
Google’s data deal with Ascension Health that was announced last week yet again reinforces why patients and advocacy groups need to be included, from the start, on major contracts involving personal health information (PHI).
Topics:
Health
|
Data and Analytics
Topics:
Health & Wellness
Unintended Consequences of Colorado’s New Pricing Disclosure Legislation
A new Colorado law requires that pharmaceutical manufacturers communicate wholesale average cost (WAC) pricing details to prescribers through either primary detailing or non-personal promotion (NPP) such as email or third-party messaging. Learn more about this law here.
Topics:
Health
Leveraging HCP Migration to Optimize Multi-Channel Spend
One of the biggest challenges that launch brands in unique therapeutic areas face is identifying the right target audience for both unbranded and branded messaging. The right audience can impact speed to market, awareness and trial, business impact, and ROI.
Topics:
Health
Topics:
Health & Wellness
Marketing to Dr. You
Topics:
Health & Wellness
Connecting the 5 Spheres of People-Based Marketing
Five people-focused domains must be mastered in order to measure and manage individual relationships, better align influencer programs, and optimize the overall cumulative impact on behavior.
Topics:
Health & Wellness
|
Analytics
